| Product Code: ETC6736430 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Sumit Sagar | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 China Angioedema Market Overview |
3.1 China Country Macro Economic Indicators |
3.2 China Angioedema Market Revenues & Volume, 2021 & 2031F |
3.3 China Angioedema Market - Industry Life Cycle |
3.4 China Angioedema Market - Porter's Five Forces |
3.5 China Angioedema Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 China Angioedema Market Revenues & Volume Share, By Route Of Administration, 2021 & 2031F |
3.7 China Angioedema Market Revenues & Volume Share, By Disease Indication, 2021 & 2031F |
3.8 China Angioedema Market Revenues & Volume Share, By Therapy, 2021 & 2031F |
3.9 China Angioedema Market Revenues & Volume Share, By Distribution Channel, 2021 & 2031F |
3.10 China Angioedema Market Revenues & Volume Share, By End-User, 2021 & 2031F |
4 China Angioedema Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing awareness about angioedema among healthcare professionals and patients in China |
4.2.2 Growing investments in healthcare infrastructure and research and development in the country |
4.2.3 Rising prevalence of angioedema cases in China due to factors such as pollution, changing lifestyles, and genetic predisposition |
4.3 Market Restraints |
4.3.1 Limited access to advanced treatment options and therapies for angioedema in China |
4.3.2 Challenges related to high treatment costs and affordability for patients |
4.3.3 Lack of standardized protocols and guidelines for the diagnosis and management of angioedema in China |
5 China Angioedema Market Trends |
6 China Angioedema Market, By Types |
6.1 China Angioedema Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 China Angioedema Market Revenues & Volume, By Product Type, 2021- 2031F |
6.1.3 China Angioedema Market Revenues & Volume, By Solid Dosage Form, 2021- 2031F |
6.1.4 China Angioedema Market Revenues & Volume, By Liquid Dosage Form, 2021- 2031F |
6.2 China Angioedema Market, By Route Of Administration |
6.2.1 Overview and Analysis |
6.2.2 China Angioedema Market Revenues & Volume, By Parenteral Route, 2021- 2031F |
6.2.3 China Angioedema Market Revenues & Volume, By Subcutaneous, 2021- 2031F |
6.2.4 China Angioedema Market Revenues & Volume, By Intravenous, 2021- 2031F |
6.2.5 China Angioedema Market Revenues & Volume, By Oral Route, 2021- 2031F |
6.3 China Angioedema Market, By Disease Indication |
6.3.1 Overview and Analysis |
6.3.2 China Angioedema Market Revenues & Volume, By Acquired Angioedema, 2021- 2031F |
6.3.3 China Angioedema Market Revenues & Volume, By Idiopathic Angioedema, 2021- 2031F |
6.3.4 China Angioedema Market Revenues & Volume, By Allergic Angioedema, 2021- 2031F |
6.3.5 China Angioedema Market Revenues & Volume, By Drug-Induced Angioedema, 2021- 2031F |
6.3.6 China Angioedema Market Revenues & Volume, By Hereditary Angioedema, 2021- 2031F |
6.4 China Angioedema Market, By Therapy |
6.4.1 Overview and Analysis |
6.4.2 China Angioedema Market Revenues & Volume, By Idiopathic Angioedema Drug Class, 2021- 2031F |
6.4.3 China Angioedema Market Revenues & Volume, By Antihistamine, 2021- 2031F |
6.4.4 China Angioedema Market Revenues & Volume, By Corticosteroids, 2021- 2031F |
6.4.5 China Angioedema Market Revenues & Volume, By Glucocorticoids, 2021- 2031F |
6.4.6 China Angioedema Market Revenues & Volume, By Adrenaline Injection, 2021- 2031F |
6.4.7 China Angioedema Market Revenues & Volume, By Hereditary Angioedema Drug Class, 2021- 2031F |
6.4.8 China Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.4.9 China Angioedema Market Revenues & Volume, By Selective Bradykinin B2 Receptor Antagonist, 2021- 2031F |
6.5 China Angioedema Market, By Distribution Channel |
6.5.1 Overview and Analysis |
6.5.2 China Angioedema Market Revenues & Volume, By Hospital Pharmacies, 2021- 2031F |
6.5.3 China Angioedema Market Revenues & Volume, By Retail Pharmacies, 2021- 2031F |
6.5.4 China Angioedema Market Revenues & Volume, By Online Pharmacies, 2021- 2031F |
6.6 China Angioedema Market, By End-User |
6.6.1 Overview and Analysis |
6.6.2 China Angioedema Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.6.3 China Angioedema Market Revenues & Volume, By Homecare Settings, 2021- 2031F |
6.6.4 China Angioedema Market Revenues & Volume, By Clinics, 2021- 2031F |
7 China Angioedema Market Import-Export Trade Statistics |
7.1 China Angioedema Market Export to Major Countries |
7.2 China Angioedema Market Imports from Major Countries |
8 China Angioedema Market Key Performance Indicators |
8.1 Number of healthcare professionals trained in diagnosing and managing angioedema |
8.2 Percentage increase in the adoption of advanced treatment options for angioedema in China |
8.3 Number of research studies and clinical trials conducted on angioedema treatments in the country |
9 China Angioedema Market - Opportunity Assessment |
9.1 China Angioedema Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 China Angioedema Market Opportunity Assessment, By Route Of Administration, 2021 & 2031F |
9.3 China Angioedema Market Opportunity Assessment, By Disease Indication, 2021 & 2031F |
9.4 China Angioedema Market Opportunity Assessment, By Therapy, 2021 & 2031F |
9.5 China Angioedema Market Opportunity Assessment, By Distribution Channel, 2021 & 2031F |
9.6 China Angioedema Market Opportunity Assessment, By End-User, 2021 & 2031F |
10 China Angioedema Market - Competitive Landscape |
10.1 China Angioedema Market Revenue Share, By Companies, 2024 |
10.2 China Angioedema Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here